Literature DB >> 1368267

By-passing immunization: building high affinity human antibodies by chain shuffling.

J D Marks1, A D Griffiths, M Malmqvist, T P Clackson, J M Bye, G Winter.   

Abstract

Diverse antibody libraries can be displayed on the surface of filamentous bacteriophage, and selected by panning of the phage with antigen. This allows human antibodies to be made directly in vitro without prior immunization, thus mimicking the primary immune response. Here we have improved the affinity of one such "primary" antibody by sequentially replacing the heavy and light chain variable (V) region genes with repertoires of V-genes (chain shuffling) obtained from unimmunized donors. For a human phage antibody for the hapten 2-phenyloxazol-5-one (phOx) (Kd = 3.2 x 10(-7) M), we shuffled the light chains and isolated an antibody with a 20 fold improved affinity. By shuffling the first two hypervariable loops of the heavy chain, we isolated an antibody with a further 15-fold improved affinity. The reshuffled antibody differed in five of the six hypervariable loops from the original antibody and the affinity for phOx (Kd = 1.1 x 10(-9) M) was comparable to that of mouse hybridomas from the tertiary immune response. Reshuffling offers an alternative to random point mutation for affinity maturation of human antibodies in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1368267     DOI: 10.1038/nbt0792-779

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  66 in total

1.  By-passing selection: direct screening for antibody-antigen interactions using protein arrays.

Authors:  L J Holt; K Büssow; G Walter; I M Tomlinson
Journal:  Nucleic Acids Res       Date:  2000-08-01       Impact factor: 16.971

2.  Selecting open reading frames from DNA.

Authors:  Paola Zacchi; Daniele Sblattero; Fiorella Florian; Roberto Marzari; Andrew R M Bradbury
Journal:  Genome Res       Date:  2003-05       Impact factor: 9.043

Review 3.  Recombinant antibodies for the diagnosis and treatment of cancer.

Authors:  Jürgen Krauss
Journal:  Mol Biotechnol       Date:  2003-09       Impact factor: 2.695

4.  Shuffled antibody libraries created by in vivo homologous recombination and yeast surface display.

Authors:  Jeffrey S Swers; Brenda A Kellogg; K Dane Wittrup
Journal:  Nucleic Acids Res       Date:  2004-02-20       Impact factor: 16.971

Review 5.  Adapting antibodies for clinical use.

Authors:  R E Hawkins; M B Llewelyn; S J Russell
Journal:  BMJ       Date:  1992-11-28

Review 6.  Accessing the human repertoire for broadly neutralizing HIV antibodies.

Authors:  Philip W Hammond
Journal:  MAbs       Date:  2010 Mar-Apr       Impact factor: 5.857

7.  Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization.

Authors:  Hongyuan Mao; James J Graziano; Tyson M A Chase; Cornelia A Bentley; Omar A Bazirgan; Neil P Reddy; Byeong Doo Song; Vaughn V Smider
Journal:  Nat Biotechnol       Date:  2010-10-24       Impact factor: 54.908

Review 8.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

Review 9.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics.

Authors:  H J de Haard; B Kazemier; M J Koolen; L J Nijholt; R H Meloen; B van Gemen; H R Hoogenboom; J W Arends
Journal:  Clin Diagn Lab Immunol       Date:  1998-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.